FDA approves new pill for menopausal hot flashes.
TL;DR Summary
The FDA has approved Veozah, the first nonhormonal medication to treat hot flashes in menopausal women. The drug targets a neuron in the brain that becomes unbalanced as estrogen levels fall and is cleared for moderate to severe symptoms. Hormonal treatments including estrogen and progestin were linked to elevated risks of blood clots and strokes decades ago. The drug would cost $550 for a 30-day supply, not including rebates, and would be available in pharmacies within three weeks of approval.
- F.D.A. Approves New Drug to Treat Hot Flashes The New York Times
- FDA green lights a new type of drug for menopausal hot flashes CNN
- New menopause drug for hot flashes gets FDA approval ABC News
- US FDA approves Astellas Pharma pill for menopause hot flashes Reuters
- FDA OKs New Drug for Hot Flashes Medscape
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
82%
452 → 80 words
Want the full story? Read the original article
Read on The New York Times